*Helio Zangrossi Jr1, Jefferson Nascimento Silva1, Paloma Molina Hernandes1, Arthur Rocha Gomes1, Sabrina de Souza Lisboa2 (1. School of Medicine of Riberao Preto, University of Sao Paulo, 2. Faculty of Pharmaceutical Sciences of Ribeirao Preto, USP)
Session information
[CINP2024] Poster Session
CINP2024 » Poster Session
Preclinical - Others (1)
Sat. May 25, 2024 4:50 PM - 5:50 PM CINP Poster Session Hall (Lobby Gallery)
*Seico Benner1, Toshihiro Endo2, Hidenori Yamasue3 (1. National Institute for Environmental Studies (NIES), Tsukuba, Japan, 2. Phenovance LLC, Kashiwa, Japan, 3. Hamamatsu University School of Medicine, Hamamatsu, Japan)
*Masato Okitsu1,2, Masayo Fujita1, Kazushi Takahashi2, Kazutaka Ikeda1 (1. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2. Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan)
*Henrieta Oravcova1, Daniil Grinchii2, Zuzana Romanova1, Lubica Lacinova2, Eliyahu Dremencov2, Daniela Jezova1 (1. Institute of Experimental Endocrinology, Biomedical research center, Slovak academy of Sciences, 2. Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences)
*Kathleen Frances Vincent1,2, Angel J Cho3,1, Ken Solt1,2 (1. Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA, 2. Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA, 3. Touro College of Osteopathic Medicine, New York, New York, USA)
*Yosuke Matsubara1, Keita Mizuno1, Yoshiki Ikeda1, Mitsutaka Yakabe2, Sumito Ogawa2 (1. Tsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, Japan, 2. Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan)
Kazuki Fujii1,2,3, Yumie Koshidaka2, Mayumi Adachi2, Yuko Yanagibashi2, Mina Matsuo2, Shoko Hongo2, Hirofumi Nishizono4, Ichiro Takasaki5, Nobuyuki Kurosawa6,7, Yasunori Aizawa8,9, *Keizo Takao1,2,3,7 (1. Department of Behavioral Physiology, Faculty of Medicine, University of Toyama, Toyama, Japan, 2. Life Science Research Center, University of Toyama, Toyama, Japan, 3. Research Center for Idling Brain Science, University of Toyama, Toyama, Japan, 4. Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan, 5. Department of Pharmacology, Graduate School of Science and Engineering, University of Toyama, Toyama, Japan, 6. Laboratory of Molecular and Cellular Biology, Department of Life Sciences and Bioengineering, Faculty of Engineering, University of Toyama, Toyama, Japan, 7. Center for Advanced Antibody Drug Development, University of Toyama, Toyama, Japan, 8. Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, Yokohama, Japan, 9. Kanagawa Institute of Industrial Science and Technology, Ebina, Japan)
*Tadashi Saigusa1, Koji Saito1, Yuri Aono1 (1. Department of Pharmacology, Nihon University School of Dentistry at Matsudo, Chiba, Japan)
*Toshinori Yoshioka1, Daisuke Yamada1, Mayuna Yamazaki1, Takumi Hamano1, Sayaka Kimiki1, Hiroshi Nagase2, Akiyoshi Saitoh1 (1. Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan, 2. University of Tsukuba, Ibaraki, Japan)
*Wakana Nagano1, Junpei Takahashi1, Daisuke Yamada1, Yoshitake Sano2, Teiichi Furuichi2, Akiyoshi Saitoh1 (1. Laboratory of Pharmacology, Faculty of Pharmacology, Tokyo University of Science, Chiba, Japan, 2. Laboratory of Molecular Neuroscience, Faculty of Science and technology, Tokyo University of Science, Chiba, Japan)
*Keiko Ikemoto1 (1. The University of Tokyo)
*Sebastian Klug1,2, Murray B. Reed1,2, Chrysoula Vraka3, Godber M Godbersen1,2, Arkadiusz Komorowski1,2, Pia Falb1,2, Lukas Nics3, Tatjana Traub-Weidinger3, Marcus Hacker3, Rupert Lanzenberger1,2, Andreas Hahn1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria, 3. Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Austria)
*Sang Won Lee1,2, Kyungmin Kim1,2, Min Seok Kim2 (1. Department of Psychiatry, Kyungpook National University Chilgok Hospital, 2. Department of Psychiatry, School of Medicine, Kyungpook National University)
*Wakako Fujita1,2 (1. Laboratory of Pharmacotherapeutics, Faculty of Pharmacy, Juntendo University., 2. Department of Medical Pharmacology, Nagasaki University Graduate School of Biomedical Sciences.)